Verdad Advisers »

Zentalis Pharmaceuticals shares owned by Verdad Advisers

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $192k 40k 4.85

More positions owned by Verdad Advisers

Apple (AAPL)
Belite Bio Sponsored Ads (BLTE)
ACADIA Pharmaceuticals (ACAD)
Comcast Corp Cl A (CMCSA)
Chatham Lodging Trust (CLDT)
Tenax Therapeutics Com New (TENX)
Slide Ins Hldgs (SLDE)
Zymeworks Del (ZYME)
AMN Healthcare Services (AMN)
X4 Pharmaceuticals Com New (XFOR)
Versant Media Group Com Cl A (VSNT)
NetScout Systems (NTCT)
Aadi Bioscience (WHWK)
Johnson & Johnson (JNJ)
Contineum Therapeutics Cl A (CTNM)

View all positions for Verdad Advisers

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
BlackRock
Two Sigma Investments
Vanguard Capital Management
Acadian Asset Management
Citadel Advisors
Renaissance Technologies
Opaleye Management
OrbiMed Advisors
Decheng Capital
Geode Capital Management
Bank of America Corporation
PRIMECAP Management Company
Pfizer

View all funds holding Zentalis Pharmaceuticals